Alector (ALEC) Interest Coverage Ratio (2019 - 2026)
Alector (ALEC) posted quarterly Interest Coverage Ratio of 123.98 for Q1 2026, up 40.64% year-over-year from 88.15 in Q1 2025, and down 99.6% quarter-over-quarter from 62.11 in Q4 2025.
Alector (ALEC) Interest Coverage Ratio (2019 - 2026) Analysis & Trends
Alector (ALEC) has reported Interest Coverage Ratio for 8 consecutive years, with 123.98 the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest Coverage Ratio rose 40.64% year-over-year to 123.98; the TTM figure through Mar 2026 stood at 13.97 (up 14.7% YoY), while the FY2025 annual figure was 5.12, up 65.37% from the prior year.
- Interest Coverage Ratio eased to 123.98 in Q1 2026 per ALEC's latest filing, from 62.11 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 2.48 in Q2 2022 and bottomed at 4267.25 in Q2 2025.
- Historically, Interest Coverage Ratio has averaged 578.57 across 5 years, with a median of 93.04 in 2025.
- Annual changes were most pronounced in 2022 — Interest Coverage Ratio soared 481.72% — and 2025, when it sank 7354.59%.
- Alector's Interest Coverage Ratio stood at 0.34 in 2022, then surged by 31.24% to 0.23 in 2023, then slumped by 259.17% to 0.83 in 2024, then tumbled by 7354.59% to 62.11 in 2025, then plunged by 99.6% to 123.98 in 2026.
- Business Quant data shows ALEC's Interest Coverage Ratio at 123.98 in Q1 2026, 62.11 in Q4 2025, and 1567.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.84 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 24.64 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.19 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.18 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.01 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.61 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.82 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.08 |
| 10 | Alector | 218.85 Mn | 46.05 Mn | - | -251.47 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -251.47 |
| Mar 31, 2026 | -123.98 |
| Dec 31, 2025 | -62.11 |
| Sep 30, 2025 | -1,567.00 |
| Jun 30, 2025 | -4,267.25 |
| Mar 31, 2025 | -208.86 |
| Dec 31, 2024 | -0.83 |
| Sep 30, 2024 | -2,018.08 |
| Jun 30, 2024 | -337.82 |
| Mar 31, 2024 | -238.84 |
| Dec 31, 2023 | -0.23 |
| Sep 30, 2023 | -404.66 |
| Jun 30, 2023 | -20.28 |
| Dec 31, 2022 | -0.34 |
| Sep 30, 2022 | -7.08 |
| Jun 30, 2022 | 2.48 |
| Mar 31, 2022 | -2.28 |
| Dec 31, 2021 | -58.66 |
| Sep 30, 2021 | 1.36 |
| Jun 30, 2021 | -0.65 |